
Masimo O3® Regional Oximetry Wins FDA Clearance for Expanded Delta Hemoglobin Use
Masimo Secures FDA Clearance for Expanded Use of O3® Regional Oximetry Delta Hemoglobin Parameters Across All Patient Populations Masimo has announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the expanded use of its O3®…











